Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Officer SHALLCROSS STEVEN A
Dec 15, 2023 16:07 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director Wolf Jeffrey Alan
Dec 15, 2023 16:01 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director Kraws Jeffrey J
Dec 15, 2023 16:00 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director MONAHAN JOHN J
Dec 15, 2023 16:00 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Officer SHALLCROSS STEVEN A
Jun 8, 2023 07:00 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Officer SHALLCROSS STEVEN A
Jun 7, 2023 07:00 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Feb 13, 2023 06:06 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Feb 3, 2023 06:02 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Jan 26, 2023 06:03 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Jan 23, 2023 06:08 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Jan 3, 2023 06:04 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Dec 16, 2022 18:17 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Dec 16, 2022 18:17 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Dec 16, 2022 18:17 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Dec 16, 2022 18:16 ET
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Dec 16, 2022 18:16 ET
Synthetic Biologics | D: Filing D
Aug 3, 2022 18:30 ET
Synthetic Biologics | 3: Initial statement of beneficial ownership of securities-Chief Operating Officer Tufaro Francis
Mar 23, 2022 18:03 ET
Synthetic Biologics | D: Filing D
Mar 21, 2022 10:55 ET
Synthetic Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Abbe(1.92%),Iroquois Capital Management L.L.C.(0.89%), etc.
Feb 23, 2022 16:42 ET
No Data
No Data